Digital Pathology Solution Resolves the Tissue Floater Conundrum
|
By LabMedica International staff writers Posted on 30 Jul 2020 |

Image: The Aperio AT2 is the ideal digital pathology slide scanner for high-throughput clinical laboratories, delivering precise eSlides with low rescan rate (Photo courtesy of Leica Biosystems).
In routine clinical practice, pathologists may encounter extraneous pieces of tissue on glass slides that could be because of contamination from other specimens. These are typically called tissue floaters. The dilemma pathologists often face is whether such a tissue floater truly belongs to the case in question, or if instead it represents a true contaminant from another patient’s sample in which case it should be ignored.
There are currently several measures a pathologist can employ to troubleshoot the tissue floater problem. Akin to forensic analysis, some laboratories have implemented molecular techniques (e.g., DNA fingerprinting for tissue identity testing) to try resolve this problem by dissecting, testing, and then comparing the molecular results of the tissue floater to the adjacent patient sample on the glass slide.
Clinical Pathologists at the University of Michigan (Ann Arbor, MI, USA) and their colleagues demonstrated the feasibility of using an image search tool to resolve the tissue floater conundrum. A glass slide was produced containing two separate hematoxylin and eosin (H&E)-stained tissue floaters. This fabricated slide was digitized along with the two slides containing the original tumors used to create these floaters. These slides were then embedded into a dataset of 2,325 whole slide images comprising a wide variety of H&E stained diagnostic entities. Digital slides were broken up into patches and the patch features converted into barcodes for indexing and easy retrieval. A deep learning-based image search tool was employed to extract features from patches via barcodes, hence enabling image matching to each tissue floater.
All three slides were then entirely digitized at ×40 magnification using an Aperio AT2 whole slide scanner (Leica Biosystems, Richmond, IL, USA). The quality of these digital slides was checked to avoid inclusion of unique identifiers All the slides were then entirely digitized at ×40 magnification using an Aperio AT2 scanner. The quality of these digital slides was checked to avoid inclusion of unique identifiers. These whole slide images (WSIs) included cases from a wide variety of anatomic sites (e.g., colon, brain, thyroid, prostate, breast, kidney, salivary gland, skin, soft tissue, etc.) exhibiting varied diagnostic pathologic entities (i.e., reactive, inflammatory, benign neoplasms, and malignancies).
The scientists reported that there was a very high likelihood of finding a correct tumor match for the queried tissue floater when searching the digital database. Search results repeatedly yielded a correct match within the top three retrieved images. The retrieval accuracy improved when greater proportions of the floater were selected. The time to run a search was completed within several milliseconds. The image search results for matching tissue floaters when using the UPMC 300 WSI pilot dataset showed that the median rank best result for both the bladder and colon tumor was 1 (95% CI =1) when selecting 5% up to 100% of the floater region.
The authors concluded that using an image search tool offers pathologists an additional method to rapidly resolve the tissue floater conundrum, especially for those laboratories that have transitioned to going fully digital for primary diagnosis. The study was published on July 15, 2020 in the journal Archives of Pathology & Laboratory Medicine.
There are currently several measures a pathologist can employ to troubleshoot the tissue floater problem. Akin to forensic analysis, some laboratories have implemented molecular techniques (e.g., DNA fingerprinting for tissue identity testing) to try resolve this problem by dissecting, testing, and then comparing the molecular results of the tissue floater to the adjacent patient sample on the glass slide.
Clinical Pathologists at the University of Michigan (Ann Arbor, MI, USA) and their colleagues demonstrated the feasibility of using an image search tool to resolve the tissue floater conundrum. A glass slide was produced containing two separate hematoxylin and eosin (H&E)-stained tissue floaters. This fabricated slide was digitized along with the two slides containing the original tumors used to create these floaters. These slides were then embedded into a dataset of 2,325 whole slide images comprising a wide variety of H&E stained diagnostic entities. Digital slides were broken up into patches and the patch features converted into barcodes for indexing and easy retrieval. A deep learning-based image search tool was employed to extract features from patches via barcodes, hence enabling image matching to each tissue floater.
All three slides were then entirely digitized at ×40 magnification using an Aperio AT2 whole slide scanner (Leica Biosystems, Richmond, IL, USA). The quality of these digital slides was checked to avoid inclusion of unique identifiers All the slides were then entirely digitized at ×40 magnification using an Aperio AT2 scanner. The quality of these digital slides was checked to avoid inclusion of unique identifiers. These whole slide images (WSIs) included cases from a wide variety of anatomic sites (e.g., colon, brain, thyroid, prostate, breast, kidney, salivary gland, skin, soft tissue, etc.) exhibiting varied diagnostic pathologic entities (i.e., reactive, inflammatory, benign neoplasms, and malignancies).
The scientists reported that there was a very high likelihood of finding a correct tumor match for the queried tissue floater when searching the digital database. Search results repeatedly yielded a correct match within the top three retrieved images. The retrieval accuracy improved when greater proportions of the floater were selected. The time to run a search was completed within several milliseconds. The image search results for matching tissue floaters when using the UPMC 300 WSI pilot dataset showed that the median rank best result for both the bladder and colon tumor was 1 (95% CI =1) when selecting 5% up to 100% of the floater region.
The authors concluded that using an image search tool offers pathologists an additional method to rapidly resolve the tissue floater conundrum, especially for those laboratories that have transitioned to going fully digital for primary diagnosis. The study was published on July 15, 2020 in the journal Archives of Pathology & Laboratory Medicine.
Latest Pathology News
- AI Tool Predicts Chemotherapy Response in Small Cell Lung Cancer
- Tumor-Specific Biomarker Predicts Neoadjuvant Immunotherapy Response in Gastric Cancer
- AI Tool Predicts Patient-Specific Chemotherapy Benefit in Breast Cancer
- AI-Based Pathology Model Guides Chemotherapy Decisions in Breast Cancer
- Biopsy-Based Gene Test Predicts Recurrence Risk in Lung Adenocarcinoma
- New Chromogenic Culture Media Enable Rapid Detection of Candida Infections
- AI-Powered Tool to Transform Dermatopathology Workflow
- AI Tool Predicts Chemotherapy Response from Biopsy Slides
- Sex Differences in Alzheimer’s Biomarkers Linked to Faster Cognitive Decline
- World’s First Optical Microneedle Device to Enable Blood-Sampling-Free Clinical Testing
- Novel mcPCR Technology to Transform Testing of Clinical Samples
- Pathogen-Agnostic Testing Reveals Hidden Respiratory Threats in Negative Samples
- Molecular Imaging to Reduce Need for Melanoma Biopsies
- Urine Specimen Collection System Improves Diagnostic Accuracy and Efficiency
- AI-Powered 3D Scanning System Speeds Cancer Screening
- Single Sample Classifier Predicts Cancer-Associated Fibroblast Subtypes in Patient Samples
Channels
Clinical Chemistry
view channelNext Generation Automated Analyzers Increase Throughput for Clinical Chemistry and Electrolyte Testing
Clinical laboratories continue to face staffing shortages, limited space, and growing test volumes that pressure chemistry and electrolyte workflows. Maintaining rapid turnaround times increasingly depends... Read more
Blood Metabolite Test Detects Early Cognitive Decline
Timely identification of individuals at risk of dementia remains difficult because symptoms commonly appear only after significant neurodegeneration. Accessible screening tools that flag subtle cognitive... Read moreMolecular Diagnostics
view channel
Immune Signatures in Blood Help Inform Cancer Risk in Lynch Syndrome
Lynch syndrome is a hereditary condition that increases risk for colorectal and endometrial cancers and often results in earlier-onset disease. Clinicians need better ways to stratify asymptomatic carriers... Read more
Genetic Marker Predicts Early Heart Failure in Pulmonary Arterial Hypertension
Pulmonary arterial hypertension is a progressive condition characterized by obstructed pulmonary blood flow and strain on the right heart, with half of patients dying within five years of diagnosis.... Read more
Genomic Subtyping Assays Identify High-Risk Early-Stage Breast Cancers
Racial survival disparities in early-stage breast cancer remain a persistent clinical concern in the United States, with Black women experiencing higher mortality despite similar treatments.... Read more
cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample
Early, accurate detection of cancer and organ disease remains limited by cost, reliance on targeted mutation assays, and uncertainty about the signal’s tissue of origin. Many liquid biopsy approaches require... Read moreHematology
view channel
Open Multi-Omics Platform Identifies Prognostic Subtypes in Blood Cancers
Blood cancers encompass diverse entities whose biology and clinical behavior are best understood through integrative analyses across large cohorts. However, multi‑omic datasets and outcomes information... Read more
AI-Powered Digital Workflow Standardizes Bone Marrow Aspirate Morphology
Bone marrow aspirate examination is central to diagnosing and monitoring blood cancers and other serious hematologic diseases, yet the process in many laboratories remains manual and highly dependent on... Read moreImmunology
view channelCombined Screening Approach Identifies Early Leprosy Cases
Leprosy remains a significant public health concern, with more than 200,000 new cases reported globally each year and early disease often escaping routine laboratory detection. In its initial phase, bacterial... Read more
Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection
Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas
Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read moreMicrobiology
view channel
New Bacterial Target Identified for Early Detection of Noma
Noma is a rapidly progressing orofacial infection that begins as gingivitis and can destroy oral and facial tissues, primarily affecting young children living in extreme poverty. Without treatment, it... Read more
Genomic Analysis Links Emerging Streptococcal Strains to Specific Infections
Streptococcus dysgalactiae subspecies equisimilis (SDSE) infections are increasing worldwide and include variants that may lead to severe disease. Researchers now report that whole-genome sequencing of... Read moreTechnology
view channel
New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
Children with T-cell acute lymphoblastic leukemia face an aggressive disease that remains difficult to treat. Although remission rates have improved, many survivors experience long-term effects from intensive... Read more
Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection
Mass spectrometry is central to identifying and quantifying molecules in complex biological samples, but conventional instruments typically analyze ions sequentially, which can limit detection of rare species.... Read moreIndustry
view channelGlobal Partnership Aims to Streamline NGS Tumor Profiling in Oncology Trials
CellCarta and Pillar Biosciences announced a global, multi-year strategic partnership on April 2, 2026 to broaden access to operationally streamlined next-generation sequencing (NGS) tumor profiling for... Read more







